Thomas L. Lemke et David A. Williams, Foye's Principles of Medicinal Chemistry, Lippincott Williams & Wilkins, , 1409– (ISBN978-1-60913-345-0, lire en ligne)
Gretchen M Lentz, Rogerio A. Lobo, David M Gershenson et Vern L. Katz, Comprehensive Gynecology, Elsevier Health Sciences, , 256– (ISBN978-0-323-09131-2, lire en ligne)
(en) Pamela S. Lotke, Contraception, An Issue of Obstetrics and Gynecology Clinics, E-Book, Elsevier Health Sciences, (ISBN9780323402590, lire en ligne), p. 634
Richard Pattman, Nathan Sankar, Pauline Handy et David Ashley Price, Oxford Handbook of Genitourinary Medicine, HIV, and Sexual Health, OUP Oxford, (ISBN9780199571666, lire en ligne), p. 368
Helen Carcio et R. Mimi Secor, Advanced Health Assessment of Women, Third Edition: Clinical Skills and Procedures, Springer Publishing Company, , 411– (ISBN978-0-8261-2308-4, lire en ligne)
E. J. Mayeaux, The Essential Guide to Primary Care Procedures, Lippincott Williams & Wilkins, , 589– (ISBN978-1-4511-5286-9, lire en ligne)
(en) Jnos Fischer et C. Robin Ganellin, Analogue-based Drug Discovery, John Wiley & Sons, (ISBN9783527607495, lire en ligne), p. 480
Pramilla Senanayake et Malcolm Potts, Atlas of Contraception, Second Edition, 2, (ISBN9780203347324, lire en ligne), p. 53
David E. Golan, Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy, Lippincott Williams & Wilkins, , 521– (ISBN978-0-7817-8355-2, lire en ligne)
Leon Speroff et Philip D. Darney, A Clinical Guide for Contraception, Lippincott Williams & Wilkins, , 365– (ISBN978-1-60831-610-6, lire en ligne)
Mary C. Brucker et Tekoa L. King, Pharmacology for Women's Health, Jones & Bartlett Publishers, , 368– (ISBN978-1-284-05748-5, lire en ligne)
Donna Shoupe, The Handbook of Contraception: A Guide for Practical Management, Springer Science & Business Media, , 16– (ISBN978-1-59745-150-5, lire en ligne).
Benno Clemens Runnebaum, Thomas Rabe et Ludwig Kiesel, Female Contraception: Update and Trends, Springer Science & Business Media, , 156–163 p. (ISBN978-3-642-73790-9, lire en ligne)
Jeremy A. Holtsclaw, Progress Towards the Total Synthesis of Desogestrel and the Development of a New Chiral Dihydroimidazol-2-ylidene Ligand, University of Michigan., (lire en ligne), p. 25 :
« In 1981, desogestrel was marketed as a new low dose oral contraceptive under the trade names Marvelon and Desogen.32 »
« Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant », International Journal of Gynaecology and Obstetrics, vol. 90, no 3, , p. 228–33 (PMID16043175, DOI10.1016/j.ijgo.2005.06.007)
« Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia », Contraception, vol. 71, no 4, , p. 306–8 (PMID15792651, DOI10.1016/j.contraception.2004.10.005)
Nappi, Merki-Feld, Terreno et Pellegrinelli, « Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? », The Journal of Headache and Pain, vol. 14, no 1, , p. 66 (PMID24456509, PMCID3735427, DOI10.1186/1129-2377-14-66)
« Implanon: a review of the literature with recommendations for clinical management », Journal of Midwifery & Women's Health, vol. 54, no 2, , p. 142–9 (PMID19249660, DOI10.1016/j.jmwh.2008.09.004).
« An assessment of the use of Implanon in three community services », The Journal of Family Planning and Reproductive Health Care, vol. 28, no 4, , p. 193–6 (PMID12419059, DOI10.1783/147118902101196540)
« Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials », Contraception, vol. 65, no 1, , p. 63–74 (PMID11861056, DOI10.1016/s0010-7824(01)00289-x)
Vieira, Bahamondes, de Souza et Brito, « Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women », Journal of Acquired Immune Deficiency Syndromes, vol. 66, no 4, , p. 378–385 (ISSN1944-7884, PMID24798768, DOI10.1097/QAI.0000000000000189)
« Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant », Fertility and Sterility, vol. 69, no 4, , p. 714–21 (PMID9548163, DOI10.1016/s0015-0282(98)00015-6)
« Nerve injury caused by removal of an implantable hormonal contraceptive », American Journal of Obstetrics and Gynecology, vol. 195, no 1, , p. 323–6 (PMID16813761, DOI10.1016/j.ajog.2005.09.016)
« Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel », Contraception, vol. 47, no 3, , p. 251–61. (PMID8462316, DOI10.1016/0010-7824(93)90042-6)
(en) « Nexplanon: what Implanon did next », The Journal of Family Planning and Reproductive Health Care, vol. 36, no 4, , p. 187–9. (PMID21067632, DOI10.1783/147118910793048629)
« The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices », American Journal of Obstetrics and Gynecology, vol. 181, no 5 Pt 1, , p. 1263–9 (PMID10561657, DOI10.1016/S0002-9378(99)70120-1)
« The use of silicone rubber as a carrier for prolonged drug therapy », The Journal of Surgical Research, vol. 4, no 3, , p. 139–42 (PMID14130164, DOI10.1016/s0022-4804(64)80040-8)
The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children), Geneva, World Health Organization, , 332–36 p. (ISBN9789241209946, ISSN0512-3054, hdl10665/189763).
The selection and use of essential medicines. Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children), Geneva, World Health Organization, , 332–36 p. (ISBN9789241209946, ISSN0512-3054, hdl10665/189763).
Vieira, Bahamondes, de Souza et Brito, « Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women », Journal of Acquired Immune Deficiency Syndromes, vol. 66, no 4, , p. 378–385 (ISSN1944-7884, PMID24798768, DOI10.1097/QAI.0000000000000189)
« Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant », International Journal of Gynaecology and Obstetrics, vol. 90, no 3, , p. 228–33 (PMID16043175, DOI10.1016/j.ijgo.2005.06.007)
« Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia », Contraception, vol. 71, no 4, , p. 306–8 (PMID15792651, DOI10.1016/j.contraception.2004.10.005)
Nappi, Merki-Feld, Terreno et Pellegrinelli, « Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? », The Journal of Headache and Pain, vol. 14, no 1, , p. 66 (PMID24456509, PMCID3735427, DOI10.1186/1129-2377-14-66)
« Implanon: a review of the literature with recommendations for clinical management », Journal of Midwifery & Women's Health, vol. 54, no 2, , p. 142–9 (PMID19249660, DOI10.1016/j.jmwh.2008.09.004).
« An assessment of the use of Implanon in three community services », The Journal of Family Planning and Reproductive Health Care, vol. 28, no 4, , p. 193–6 (PMID12419059, DOI10.1783/147118902101196540)
« Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials », Contraception, vol. 65, no 1, , p. 63–74 (PMID11861056, DOI10.1016/s0010-7824(01)00289-x)
Vieira, Bahamondes, de Souza et Brito, « Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women », Journal of Acquired Immune Deficiency Syndromes, vol. 66, no 4, , p. 378–385 (ISSN1944-7884, PMID24798768, DOI10.1097/QAI.0000000000000189)
« Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant », Fertility and Sterility, vol. 69, no 4, , p. 714–21 (PMID9548163, DOI10.1016/s0015-0282(98)00015-6)
« Nerve injury caused by removal of an implantable hormonal contraceptive », American Journal of Obstetrics and Gynecology, vol. 195, no 1, , p. 323–6 (PMID16813761, DOI10.1016/j.ajog.2005.09.016)
« Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel », Contraception, vol. 47, no 3, , p. 251–61. (PMID8462316, DOI10.1016/0010-7824(93)90042-6)
(en) « Nexplanon: what Implanon did next », The Journal of Family Planning and Reproductive Health Care, vol. 36, no 4, , p. 187–9. (PMID21067632, DOI10.1783/147118910793048629)
« The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices », American Journal of Obstetrics and Gynecology, vol. 181, no 5 Pt 1, , p. 1263–9 (PMID10561657, DOI10.1016/S0002-9378(99)70120-1)
« The use of silicone rubber as a carrier for prolonged drug therapy », The Journal of Surgical Research, vol. 4, no 3, , p. 139–42 (PMID14130164, DOI10.1016/s0022-4804(64)80040-8)
